文献速递肾小球疾病慢性肾脏病

胱氨酸/谷氨酸转运体介导的谷胱甘肽合成促进肾脏三级淋巴结构形成

Glutathione Synthesis via the Cystine/Glutamate Transporter Promotes the Formation of Tertiary Lymphoid Structures in the Kidney.
PubMed 文献 · J Am Soc Nephrol · 2025-08-08

在小鼠肾脏三级淋巴结构(TLS)模型中,TLS内谷胱甘肽显著蓄积且半胱氨酸耗竭,树突状细胞和成纤维细胞表达胱氨酸/谷氨酸转运体并向缺乏该转运体的淋巴细胞供应谷胱甘肽;药理学抑制该转运体可阻止TLS形成;尿谷胱甘肽浓度在小鼠和人类中均能有效检测肾脏TLS的存在,在IgA肾病患者中同样有效。

要点

  • 谷胱甘肽在肾脏TLS内蓄积,TLS中树突状细胞和成纤维细胞特异性表达胱氨酸/谷氨酸转运体。
  • 药理学抑制胱氨酸/谷氨酸转运体可阻止肾脏TLS形成。
  • 尿谷胱甘肽浓度在小鼠和人类中均可有效检测肾脏TLS的存在。

核心结论

  • 谷胱甘肽在肾脏TLS内显著蓄积,抑制胱氨酸/谷氨酸转运体可阻止TLS形成,尿谷胱甘肽可作为检测肾脏TLS的生物标志物。

研究设计与样本

  • 采用小鼠肾脏TLS模型,运用成像质谱和代谢组学分析表征TLS的代谢通路,并通过原位杂交联合免疫荧光及药理学抑制探讨关键分子的表达与功能。
  • 分析小鼠和人类尿液样本,探索可评估肾脏TLS存在的代谢物。

主要发现

  • TLS内特异性观察到谷胱甘肽显著蓄积和半胱氨酸耗竭,有TLS的肾脏谷胱甘肽浓度高于健康肾脏。
  • TLS中氧化应激标志物4-羟基壬烯醛和8-羟基-2′-脱氧鸟苷显著蓄积。
  • TLS内树突状细胞和成纤维细胞表达胱氨酸/谷氨酸转运体,并向缺乏该转运体表达的淋巴细胞供应合成的谷胱甘肽。
  • 药理学抑制胱氨酸/谷氨酸转运体阻止了肾脏TLS形成。
  • TLS内谷胱甘肽合成增强反映为小鼠和人类尿谷胱甘肽浓度升高,在IgA肾病患者中有效检测肾脏TLS的存在。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Glutathione accumulated in tertiary lymphoid structures (TLS), where dendritic cells and fibroblasts specifically expressed cystine/glutamate transporter. Pharmacologic inhibition of the cystine/glutamate transporter prevented the formation of TLS. Urinary glutathione concentrations efficiently detected the presence of TLS in the kidney in mice and humans. BACKGROUND: Tertiary lymphoid structure (TLS), an ectopic lymphoid tissue induced under chronic inflammation, develops in various kidney diseases and is associated with poor prognosis. The immune system requires metabolic resources to support immune function and lymphocyte proliferation. Hence, dramatic metabolic alterations presumably occur during the formation of TLS. However, it remains unclear whether metabolic remodeling occurs during this formation and its underlying mechanism. METHODS: In a murine model of TLS in the kidney, we used imaging mass spectrometry and metabolome analysis to investigate the metabolic pathway that characterizes TLS. We also performed in situ hybridization with immunofluorescence and pharmacologic inhibition to explore the expression and function of the key molecules governing the pivotal metabolic pathway. We analyzed urine samples from mice and humans to explore the metabolites estimating the presence of TLS in the kidney. RESULTS: Significant glutathione accumulation and depletion of cysteine, which is essential for glutathione synthesis, was observed specifically within TLS. The kidneys with TLS exhibited higher glutathione concentrations than healthy kidneys. TLS also showed significant accumulation of 4-hydroxynonenal and 8-hydroxy-2′ -deoxyguanosine, markers of oxidative stress. Dendritic cells and fibroblasts within TLS expressed the cystine/glutamate transporter, which regulates glutathione synthesis, and supplied synthesized glutathione to lymphocytes, which lacked its expression. Pharmacologic inhibition of the cystine/glutamate transporter prevented the formation of TLS in the kidney. Furthermore, enhanced glutathione synthesis within TLS was reflected in elevated urinary glutathione concentrations in both mice and humans, which effectively detected the presence of TLS in the kidney in IgA nephropathy patients. CONCLUSIONS: Glutathione significantly accumulated within TLS in the kidney. Inhibition of the cystine/glutamate transporter prevented the formation of TLS. Urinary glutathione served as a biomarker to detect TLS in the kidney.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Arai H, Sugiura Y, Yamamoto S, et al. Glutathione Synthesis via the Cystine/Glutamate Transporter Promotes the Formation of Tertiary Lymphoid Structures in the Kidney. J Am Soc Nephrol. 2025. PMID: 40779326. doi:10.1681/ASN.0000000825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。